Literature DB >> 6123339

Dose-response relation for atracurium, ORG NC 45 and pancuronium.

L Gramstad, P Lilleaasen.   

Abstract

The potencies of atracurium, Org NC 45 and pancuronium were determined using cumulative dose-response curves. The effective doses producing 95% twitch depression were 279 microgram kg-1, 56 microgram kg-1 and 64 microgram kg-1 respectively, the relative potency being 1:5.0:4.3. The calculated log-probit dose-response curves showed the steepest slope for pancuronium, although the slopes did not deviate significantly from the parallel. The three drugs provided equal and generally good intubating conditions at approximately 95% twitch depression. Greater arterial pressure and heart rate were seen with pancuronium than with atracurium and Org NC 45.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123339     DOI: 10.1093/bja/54.6.647

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

2.  Potentiation of atracurium by pancuronium and d-tubocurarine.

Authors:  H R Gerber; J Romppainen; W Schwinn
Journal:  Can Anaesth Soc J       Date:  1986-09

3.  The neuromuscular effects of sevoflurane and isoflurane alone and in combination with vecuronium or atracurium in the rat.

Authors:  Y S Shin; R D Miller; J E Caldwell; E I Eger
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

4.  Vecuronium in renal failure.

Authors:  D R Bevan; F Donati; H Gyasi; A Williams
Journal:  Can Anaesth Soc J       Date:  1984-09

Review 5.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

6.  Cumulative dose-response curves for atracurium in patients with myasthenia gravis.

Authors:  C E Smith; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

7.  Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease.

Authors:  D H Sethna; N J Starr; F G Estafanous
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

8.  Atracurium versus vecuronium: a comparison of recovery in outpatient arthroscopy.

Authors:  W W Zuurmond; L van Leeuwen
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

9.  Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with coronary artery disease.

Authors:  D H Sethna; N J Starr; F G Estafanous
Journal:  Can Anaesth Soc J       Date:  1986-05

10.  Contribution of muscle relaxant to the haemodynamic course of high-dose fentanyl anaesthesia: a comparison of pancuronium, vecuronium and atracurium.

Authors:  J Heinonen; M Salmenperä; M Suomivuori
Journal:  Can Anaesth Soc J       Date:  1986-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.